MDMA Praises Introduction of Bipartisan Medical Device Repeal Legislation
Wednesday, February 6, 2013
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding introduction in the U.S. House of Representatives of H.R. 523, the "Protect Medical Innovation Act:”
"MDMA thanks Congressman Paulsen and Congressman Kind for their continued leadership on this crucial issue for medical innovation and patient care, and we remain fully committed to repealing the device tax. There is no question that the device tax is destroying jobs, eliminating investments in research and development and shelving plans for new medical technologies, all to the detriment of patients.
"The broad, bipartisan support for repealing the medical device tax speaks volumes to the recognition by Members of Congress that the United States needs to maintain our global leadership position in this high tech, manufacturing-based industry.
"America's workers and patients have too much on the line for us to let up on our call to repeal the medical device tax, and MDMA and our members are more committed than ever to get the job done."